Who
Markus Puhlmann
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Perspective Therapeutics.
In numbers
- Trades disclosed
- 9
- Buys
- 4
- Sells
- 0
- Bought
- $328K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 12 Dec 2023
- Last trade
- 2 Mar 2026
- Last filed
- 4 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Mar 2026filed 4 Mar 2026 | CATX Perspective Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | CATX Perspective Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 3 Mar 2025filed 5 Mar 2025 | CATX Perspective Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —165,000 at $0.00 | filing |
| 20 Jun 2024filed 24 Jun 2024 | CATX Perspective Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —150,000 at $0.00 | filing |
| 24 Jan 2024filed 26 Jan 2024 | CATX Perspective TherapeuticsBiotechnology | SEC FORM 4 Bought | $140K280,000 at $0.50 | filing |
| 19 Dec 2023filed 19 Dec 2023 | CATX Perspective TherapeuticsBiotechnology | SEC FORM 4 Bought | $136K400,000 at $0.34 | filing |
| 18 Dec 2023filed 19 Dec 2023 | CATX Perspective TherapeuticsBiotechnology | SEC FORM 4 Bought | $16K60,419 at $0.26 | filing |
| 15 Dec 2023filed 19 Dec 2023 | CATX Perspective TherapeuticsBiotechnology | SEC FORM 4 Bought | $36K135,006 at $0.27 | filing |
| 12 Dec 2023filed 14 Dec 2023 | CATX Perspective Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,477,619 at $0.00 | filing |
News
FDA Grants Fast Track To Perspective Therapeutics' PSV359CATX · finanzen.ch · 8 Oct 2026Perspective Therapeutics Announces Acceptance of [212Pb]VMT-α-NET Data for Presentation at the NANETS 2026 Multidisciplinary NET Medical SymposiumCATX · manilatimes.net · 7 Oct 2026
0 headlines in the last 90 days name Markus Puhlmann; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.